Hye-Sook Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hye-Sook Kim has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Altaf Mohammed
Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland
1 shared publication - Anil Wali
National Cancer Institute 1 , Rockville, Maryland
1 shared publication - Emmanuel F. Mongodin
Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA
1 shared publication - Gabriela Riscuta
National Cancer Institute 1 , Rockville, Maryland
1 shared publication - Marco Cardone
National Cancer Institute 1 , Rockville, Maryland
1 shared publication - Mukesh Verma
National Cancer Institute 1 , Rockville, Maryland
1 shared publication
Latest Publications
- Open Access
- 1 September 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (9) , 1490-1494
The Oral Microbiome: A Silent Contributor to Systemic Health and Disease National Institutes of Health 2024 Workshop
Previously considered primarily only in the context of dental diseases, the oral microbiome is now recognized as a contributor to a variety of systemic diseases, including cancer and cardiovascular diseases. This commentary explores the evolving view of the oral cavity as a gateway to the body’s broader physiologic networks, implicating oral microbiome dysbiosis in a spectrum of chronic conditions. Drawing on current evidence, we propose a re-envisioned healthcare model that integrates oral and systemic health and outline research gaps and clinical priorities to harness the oral microbiome for preventive and therapeutic gains, emphasizing cancer-relevant biomarkers and intervention opportunities.
- 1 September 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (9) , 1490-1494
Open AccessThe Oral Microbiome: A Silent Contributor to Systemic Health and Disease National Institutes of Health 2024 Workshop
Previously considered primarily only in the context of dental diseases, the oral microbiome is now recognized as a contributor to a variety of systemic diseases, including cancer and cardiovascular diseases. This commentary explores the evolving view of the oral cavity as a gateway to the body’s broader physiologic networks, implicating oral microbiome dysbiosis in a spectrum of chronic conditions. Drawing on current evidence, we propose a re-envisioned healthcare model that integrates oral and systemic health and outline research gaps and clinical priorities to harness the oral microbiome for preventive and therapeutic gains, emphasizing cancer-relevant biomarkers and intervention opportunities.